155,395 Shares in The Cooper Companies, Inc. $COO Acquired by Korea Investment CORP

Key Points

• Korea Investment CORP acquired 155,395 shares of Cooper Companies during the second quarter, worth approximately $11.1 million and representing about 0.08% of the company. Institutional investors and hedge funds collectively own 24.39% of COO.
• Analyst sentiment is mixed, with a consensus rating of “Hold” from 17 analysts and an average price target of $81.64. Targets range from $61 to $85, including recent downgrades from JPMorgan, Stifel, and Wells Fargo.
• Cooper Companies reported quarterly EPS of $1.21, beating estimates of $1.10, while revenue rose 7.9% year over year to $1.08 billion. The stock opened at $75.80, with a one-year range of $58.89 to $89.83.

Korea Investment CORP bought a new position in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) during the second quarter, according to its most recent Form 13F filing with the SEC. The fund bought 155,395 shares of the medical device company's stock, valued at approximately $11,143,000. Korea Investment CORP owned about 0.08% of Cooper Companies at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in COO. Avalon Trust Co bought a new position in Cooper Companies during the 2nd quarter worth $25,000. Root Financial Partners LLC increased its stake in shares of Cooper Companies by 104.5% in the fourth quarter. Root Financial Partners LLC now owns 317 shares of the medical device company's stock valued at $26,000 after buying an additional 162 shares during the period. SJS Investment Consulting Inc. increased its stake in shares of Cooper Companies by 107.5% in the first quarter. SJS Investment Consulting Inc. now owns 361 shares of the medical device company's stock valued at $26,000 after buying an additional 187 shares during the period. Elevation Wealth Partners LLC raised its position in shares of Cooper Companies by 1,136.4% during the second quarter. Elevation Wealth Partners LLC now owns 408 shares of the medical device company's stock worth $29,000 after acquiring an additional 375 shares during the last quarter. Finally, J.Safra Asset Management Corp bought a new position in shares of Cooper Companies during the second quarter worth about $32,000. 24.39% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

COO has been the topic of several analyst reports. The Goldman Sachs Group set a $61.00 target price on Cooper Companies in a report on Wednesday, May 27th. UBS Group began coverage on shares of Cooper Companies in a research report on Tuesday, July 28th. They issued a "neutral" rating and a $75.00 price target on the stock. JPMorgan Chase & Co. reduced their price objective on shares of Cooper Companies from $80.00 to $71.00 and set a "neutral" rating on the stock in a research note on Friday, June 5th. Stifel Nicolaus decreased their price objective on shares of Cooper Companies from $95.00 to $85.00 and set a "buy" rating for the company in a research report on Friday, June 5th. Finally, Wells Fargo & Company reissued a "sell" rating and set a $66.00 target price (down from $82.00) on shares of Cooper Companies in a research note on Friday, June 5th. One investment analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, six have given a Hold rating and three have assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and an average price target of $81.64.

Cooper Companies Trading Down 0.6%

NASDAQ COO opened at $75.80 on Tuesday. The stock has a market capitalization of $14.78 billion, a P/E ratio of 64.24, a P/E/G ratio of 1.99 and a beta of 0.83. The business has a 50 day simple moving average of $72.09 and a 200 day simple moving average of $71.07. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.27 and a quick ratio of 0.78. The Cooper Companies, Inc. has a one year low of $58.89 and a one year high of $89.83.

Cooper Companies (NASDAQ:COO - Get Free Report) last posted its quarterly earnings results on Thursday, June 4th. The medical device company reported $1.21 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.10 by $0.11. The firm had revenue of $1.08 billion for the quarter, compared to analysts' expectations of $1.05 billion. Cooper Companies had a return on equity of 10.88% and a net margin of 5.57%.The company's revenue for the quarter was up 7.9% compared to the same quarter last year. During the same period in the prior year, the business earned $0.96 EPS. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. Research analysts expect that The Cooper Companies, Inc. will post 4.63 earnings per share for the current year.

About Cooper Companies

Cooper Companies, Inc NASDAQ: COO is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women's health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source